Hydro completed the acquisition of Vale's remaining shareholding in Mineração Paragominas S.A. (MPSA) on 15 December 2016. The transaction is the second and final step of the MPSA put/call arrangements agreed in 2011 in connection with Hydro's acquisition of the majority of Vale's aluminium assets in Brazil. Hydro now owns 100% of MPSA's shares.
Hydro's net payment, after adjustments resulting from the completion of outstanding contractual arrangements with Vale, was USD 113 million. Hydro expects the transaction to have a positive impact for Bauxite & Alumina of approximately USD 45 million on its result in the fourth quarter of 2016, of which USD 30 million will be excluded from underlying earnings.
Investor contact
Contact Olena Lepikhina
Cellular +47 96853035
E-mail [email protected]
Press contact
Contact Halvor Molland
Cellular +47 92979797
E-mail [email protected]


Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Apple Turns 50: From Garage Startup to AI Crossroads
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push 



